Literature DB >> 19682446

Evidence for an effect of clozapine on the regulation of fat-cell derived factors.

Zhi Yang1, Ji-Ye Yin, Zhi-Cheng Gong, Qiong Huang, Hao Chen, Wei Zhang, Hong-Hao Zhou, Zhao-Qian Liu.   

Abstract

OBJECTIVES: The aims of this study were to investigate the effects of clozapine on adipocyte differentiation and its regulation for fat-cell derived factors.
MATERIALS AND METHODS: 3T3-L1 preadipocytes were induced into differentiated adipocytes by the addition of 5 microg/ml of insulin, 1 micromol/l dexamethasone, 10 mmol/l IBMX, 1% DMSO, and 10% FBS in DMEM medium. The semi-quantitative RT-PCR was performed to determine the mRNA levels of PPAR gamma, C/EBP alpha, ADD1/SREBP(1C), LPL, and DGAT1. The expression levels of LPL and DGAT1 proteins in the adipocytes treated with clozapine or rosiglitazone were determined by Western blot analysis. The triglyceride concentration was determined by use of GPO-POD assay Kit.
RESULTS: Clozapine enhanced the expression level of ADD1/SREBP(1C) mRNA and triglyceride concentration in the differentiated adipocytes. Clozapine significantly suppressed the expression levels of LPL mRNA and LPL protein with a dose-dependent and time-dependent manner, respectively.
CONCLUSION: These data suggest that clozapine might play an important role in inducing adipocyte differentiation and the regulation of fat-cell derived factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682446     DOI: 10.1016/j.cca.2009.07.021

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes.

Authors:  Emilie Lauressergues; Bart Staels; Karine Valeille; Zouher Majd; Dean W Hum; Patrick Duriez; Didier Cussac
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-24       Impact factor: 3.000

Review 2.  Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia.

Authors:  Hu Yan; Jin-Dong Chen; Xiao-Yan Zheng
Journal:  Psychopharmacology (Berl)       Date:  2013-07-06       Impact factor: 4.530

3.  Peroxisome proliferator-activated receptor gamma (PPARG) Pro12Ala: lack of association with weight gain in psychiatric inpatients treated with olanzapine or clozapine.

Authors:  Julia Staeker; Stefan Leucht; Werner Steimer
Journal:  Mol Diagn Ther       Date:  2012-04-01       Impact factor: 4.074

4.  Tricyclic antipsychotics promote adipogenic gene expression to potentiate preadipocyte differentiation in vitro.

Authors:  Christopher M Cottingham; Taylor Patrick; Morgan A Richards; Kirkland D Blackburn
Journal:  Hum Cell       Date:  2020-05-23       Impact factor: 4.174

5.  Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics.

Authors:  Jee-Eun Oh; Yoon Mi Cho; Su-Nam Kwak; Jae-Hyun Kim; Kyung Won Lee; Hyosan Jung; Seong-Whan Jeong; Oh-Joo Kwon
Journal:  Exp Mol Med       Date:  2012-09-30       Impact factor: 8.718

6.  Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review.

Authors:  Haiyun Xu; Xiaoyin Zhuang
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-22       Impact factor: 2.570

7.  5-lipoxygenase-activating protein as a modulator of olanzapine-induced lipid accumulation in adipocyte.

Authors:  Svetlana Dzitoyeva; Hu Chen; Hari Manev
Journal:  J Lipids       Date:  2013-05-25

8.  Reduction of Cellular Lipid Content by a Knockdown of Drosophila PDP1 γ and Mammalian Hepatic Leukemia Factor.

Authors:  Svetlana Dzitoyeva; Hari Manev
Journal:  J Lipids       Date:  2013-08-22

Review 9.  Neuroprotective effects of psychotropic drugs in Huntington's disease.

Authors:  Edward C Lauterbach
Journal:  Int J Mol Sci       Date:  2013-11-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.